Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03576768 · ClinicalTrials.gov registry record · NA

QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt

A NA study, sponsored by Medical University of South Carolina.

Terminated
Registry status
NA
Development phase
25
Enrollment target

NCT03576768 is a NA study that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03576768, a NA study, was terminated before completion, sponsored by Medical University of South Carolina.

TERMINATED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

Cigarette smoking constitutes the greatest preventable cause of mortality and morbidity in the US. The most critical period for long term success of smoking cessation appears to be in the first 7 days after the quit date. A metaanalysis of 3 pharmacotherapy trials revealed that abstinence during the first 7 days was the strongest predictor of 6 month outcomes (n=1649; Odds ratio: 1.4, P \<0.0001; Ashare et al. 2013). Prodigious relapse rates during this first week of smoking cessation are likely due to behavioral and neurobiological factors that contribute to high cue-associated craving and low executive control over smoking. The long term goal of the research is to develop evidence-based transcranial magnetic stimulation protocols to facilitate abstinence during this critical period.

Interventions

  • DEVICE Sham cTBS
  • DEVICE Sham iTBS
  • DEVICE Real iTBS
  • DEVICE Real cTBS

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2018-09-04
Est. Completion 2019-10-25
Phase NA

What the Registry Record Tells You About NCT03576768

The ClinicalTrials.gov registry entry for NCT03576768 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Sham cTBS is the first listed.

NCT03576768 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03576768 about?

NCT03576768 is a clinical study titled "QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt". Cigarette smoking constitutes the greatest preventable cause of mortality and morbidity in the US. The most critical period for long term success of smoking cessation appears to be in the first 7 days after the quit date. A metaanalysis of 3 pharmacotherapy trials revealed that abstinence during the...

What is the current status of trial NCT03576768?

This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2018-09-04. Estimated completion is 2019-10-25.

What interventions are being tested in trial NCT03576768?

The interventions under investigation include: Sham cTBS (DEVICE), Sham iTBS (DEVICE), Real iTBS (DEVICE), Real cTBS (DEVICE).

Who is sponsoring clinical trial NCT03576768?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.